Sarepta sells Arrowhead shares as partnership, debt payments loom
Written by
BioPharma Dive
Published
0
comments
0
min
Liquidating its stake in Arrowhead helps Sarepta cover a milestone payment and secure what one analyst described as “additional breathing room” ahead of a debt maturity in 2027.